![Karen Agersborg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Agersborg
Directeur/Membre du Conseil chez
CLINUVEL PHARMACEUTICALS LIMITED
Fortune : 90 869 $ au 31/05/2026
Profil
Karen Agersborg has held positions as an Independent Non-Executive Director at Clinuvel Pharmaceuticals Ltd. since 2018 and is currently a Member at the American Osteopathic Association.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 13 833 ( 0,03 % ) | 90 869 $ | 31/05/2026 |
Postes actifs de Karen Agersborg
| Sociétés | Poste | Début |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 29/01/2018 |
American Osteopathic Association
 American Osteopathic Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for osteopathic medical doctors and students | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
American Osteopathic Association
American Osteopathic Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for osteopathic medical doctors and students | Commercial Services |
